NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K Filing

NeOnc Technologies to present clinical data for NEO100 and NEO212 programs at the Society for Neuro-Oncology Annual Meeting on November 13, 2026. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $NTHI

Read the full article at SEC EDGAR

More Regulatory news